Literature DB >> 8455530

Treatment of hyperemesis gravidarum with nasogastric feeding.

R M Gulley, N Vander Pleog, J M Gulley.   

Abstract

Hyperemesis gravidarum, an antepartem disorder characterized by severe nausea and vomiting, is usually a benign condition with a favorable outcome. Although no increase in fetal or maternal morbidity results, the disorder has deleterious effects on both nutrition and everyday life. The authors describe a treatment protocol for hyperemesis gravidarum that uses continuous infusion of an iso-osmolar tube-feeding product and their experiences with its use in 30 patients. Uniformly good symptom relief was obtained by this technique, thus avoiding the need for more invasive therapy. It is proposed that this treatment is a safe and effective means of managing severe nausea and vomiting during early pregnancy.

Entities:  

Mesh:

Year:  1993        PMID: 8455530     DOI: 10.1177/011542659300800133

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  3 in total

Review 1.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

Review 2.  Emerging Progress in Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum: Challenges and Opportunities.

Authors:  Chuan Liu; Guo Zhao; Danni Qiao; Lintao Wang; Yeling He; Mingge Zhao; Yuanyuan Fan; Enshe Jiang
Journal:  Front Med (Lausanne)       Date:  2022-01-10

3.  Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding).

Authors:  Iris J Grooten; Ben W Mol; Joris A M van der Post; Carrie Ris-Stalpers; Marjolein Kok; Joke M J Bais; Caroline J Bax; Johannes J Duvekot; Henk A Bremer; Martina M Porath; Wieteke M Heidema; Kitty W M Bloemenkamp; Hubertina C J Scheepers; Maureen T M Franssen; Martijn A Oudijk; Tessa J Roseboom; Rebecca C Painter
Journal:  BMC Pregnancy Childbirth       Date:  2016-01-27       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.